CROSS TIMBERS ROYALTY TRUST DECLARES OCTOBER CASH DISTRIBUTION
|
|
|
Underlying Sales |
|
|
||||||
|
|
|
Volumes (a) |
|
Average Price |
||||||
|
|
|
Oil (Bbls) |
|
Gas (Mcf) |
|
Oil (per Bbl) |
|
Gas (per Mcf) |
||
|
|
||||||||||
|
Current Month Distribution |
|
12,000 |
|
80,000 |
|
|
|
|
||
|
|
||||||||||
|
Prior Month Distribution |
|
14,000 |
|
111,000 |
|
|
|
|
||
|
|
||||||||||
|
(a) |
Sales volumes are recorded in the month the Trust receives the related net profits income. Because of this, sales volumes may fluctuate from month to month based on the timing of cash receipts. |
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Excess Costs
XTO Energy has advised the Trustee that excess costs increased by
XTO Energy has advised the Trustee that excess costs increased by
For more information on the Trust, including the annual tax information, distribution amounts, and historical press releases, please visit our website at www.crt-crosstimbers.com.
View original content:https://www.prnewswire.com/news-releases/cross-timbers-royalty-trust-declares-october-cash-distribution-302589976.html
SOURCE Cross Timbers Royalty Trust
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arcadis deepens Autodesk collaboration to accelerate AI and data-led delivery for clients
- Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide
- Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share